Existing data on the study of triple-negative breast cancer subtypes allowed to identify a cluster of tumors, which at the epigenome level are characterized by enrichment in immune-related pathways such as response to interferon-beta, the positive regulation of T cell-mediated cytotoxicity, or antigen processing and presentation [11]. Here, IFNB1 is linked to triple-negative breast carcinoma.